Inactive Instrument
Arix Bioscience plc Stock
Stocks
ARIX
GB00BD045071
Investment Management & Fund Operators
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Tom Davidson
DFI | Director of Finance/CFO | - | 2023-04-30 |
Laura Craig
IRC | Investor Relations Contact | - | - |
Jade Fletcher
AUD | Comptroller/Controller/Auditor | - | 2022-10-09 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 2021-04-28 | |
| Director/Board Member | 63 | 2022-08-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/31/23 | Free | Chief Executive Officer | 671,800 | 0.5200% | ||
| 5/4/23 | Sell | Chief Executive Officer | 22,238 | 0.0172% | ||
| 5/4/23 | Sell | Chief Executive Officer | 57,000 | 0.0441% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -1.05% | - | - | 235M | |
| -0.39% | -1.92% | +41.63% | +23.82% | 3.41B | |
| +0.50% | -1.10% | -9.80% | +3.71% | 3.12B | |
| +0.87% | -0.43% | +30.19% | +31.97% | 1.83B | |
| +1.10% | +1.78% | +83.46% | +201.10% | 1.42B | |
| 0.00% | 0.00% | -1.72% | -7.02% | 714M | |
| +0.99% | +3.15% | +118.26% | +259.92% | 670M | |
| +10.26% | +22.86% | -12.24% | -66.92% | 426M | |
| 0.00% | 0.00% | -3.97% | -7.05% | 401M | |
| 0.00% | 0.00% | -0.53% | -13.02% | 363M | |
| Average | +1.43% | +0.28% | +27.25% | +47.39% | 1.37B | |
| Weighted average by Cap. | +0.94% | -0.91% | +28.83% | +46.16% |
Employees
9
